Feline Toxoplasmosis: Zoonotic Risks, Clinical Manifestations, Diagnosis, and Management in Cats

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. This protozoan exhibits a complex heteroxenous life cycle, with felids serving as the definitive host in which sexual reproduction occurs. All warm-blooded vertebrates, including birds and mammals, can act as intermediate hosts [1, 2]. The life cycle involves three principal infectious stages: tachyzoites (rapidly dividing forms responsible for acute infection), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (within oocysts). Oocysts are shed exclusively in the feces of felids after sexual reproduction in the feline intestinal epithelium [2].

Following ingestion of tissue cysts or oocysts by a cat, the parasite undergoes both enteroepithelial and extraintestinal cycles. The enteroepithelial cycle culminates in gametogony and oocyst formation, a process characterized by sex-specific cell division patterns [1]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has provided high-resolution transcriptomic data on these stages, revealing the precise host cell types and parasite gene expression programs associated with oocyst production [2]. After a prepatent period of 3 to 10 days (and potentially longer depending on the infective stage), millions of unsporulated oocysts are shed in cat feces per day for 1 to 2 weeks [3].

Epidemiology and Transmission in Feline Populations

The seroprevalence of T. gondii in domestic cats varies significantly by geographic region, lifestyle, and management practices. In Hong Kong, seroprevalence among privately owned cats and community cats was assessed in relation to demographic factors such as age, sex, and housing status, with outdoor access being a major risk factor [4]. In Jordan, a seroprevalence and molecular detection survey of cats revealed that raw feeding and hunting behavior were significantly associated with infection, linking dietary exposure to tissue cysts in prey tissue [5]. Similarly, a study of cats in Baghdad, Thailand, employed PCR-based detection of T. gondii DNA in fecal samples from stray populations, confirming environmental contamination through oocyst shedding [3].

Environmental factors play a critical role in transmission dynamics. Oocysts can remain infective for months in warm, moist soil, and their distribution is influenced by social and environmental degradation [6]. In Brazil, studies have linked T. gondii exposure in urban informal settlements to social marginalization and poor sanitation, highlighting that oocyst contamination is not solely a function of cat density but also of environmental management [6]. The role of wildlife as bioindicators has also been studied; nonhuman primates and wild felids from Brazilian zoos have demonstrated seropositivity, reflecting environmental contamination in captive settings [7].

Transmission to cats occurs primarily through ingestion of tissue cysts in infected intermediate hosts (e.g., rodents, birds) or through ingestion of sporulated oocysts from contaminated soil, water, or surfaces [8]. Migratory and opportunistic wild and domestic birds serve as carriers of T. gondii, amplifying the parasite's geographic distribution and bringing the infection into feline habitats [8]. Vertical transmission (transplacental) is well documented in intermediate hosts and can occur in cats, although it is less common as a primary route of infection [9]. A study of reproductive tissues from companion animals enrolled in neutering programs confirmed that T. gondii DNA can be detected in ovarian and uterine tissues of cats, suggesting that vertical transmission is a viable, if infrequent, route [9].

Clinical Manifestations in Cats

The clinical presentation of feline toxoplasmosis ranges from subclinical infection to severe multisystemic disease. Most immunocompetent adult cats remain asymptomatic after primary infection. Clinical disease is more common in kittens, immunosuppressed cats, or those infected with highly virulent strains. The most frequently reported clinical signs include lethargy, anorexia, pyrexia, and lymphadenopathy [5]. Ocular toxoplasmosis, characterized by anterior uveitis, chorioretinitis, and secondary glaucoma, can occur as a sequela of systemic infection [10].

Neurological involvement is a well-recognized manifestation, presenting as ataxia, seizures, circling, behavioral changes, and cranial nerve deficits [11]. Fatal cerebral toxoplasmosis has been reported in immunocompromised cats, mirroring the pathogenesis seen in other species [11]. Hepatic and pulmonary toxoplasmosis may manifest as icterus or dyspnea, respectively. In pregnant queens, transplacental infection can lead to abortion, stillbirth, or neonatal mortality [12, 13]. The role of T. gondii in reproductive failure in cats has been investigated, with molecular detection confirmed in fetal and placental tissues [14, 9].

An often-overlooked area is the impact of T. gondii on host behavior. While documented in rodents, the behavioral effects in cats are less clear, though infection may contribute to altered activity or risk-taking.

Zoonotic Risks and the "Toxoplasmosis Cat Lady Disease" Stigma

The zoonotic potential of T. gondii is a central concern for veterinary public health. Humans are typically infected through ingestion of oocysts from contaminated soil, water, or cat litter, or through ingestion of tissue cysts in undercooked meat from infected intermediate hosts [15, 16]. The phrase "toxoplasmosis cat lady disease" reflects a social stigma linking cat ownership, particularly among women, to T. gondii infection. This perception is a gross oversimplification and is contradicted by epidemiological data.

While cats are the definitive host, direct contact with a cat is not the primary risk factor for human infection. Oocysts require 1 to 5 days to sporulate and become infective after being shed. Moreover, most cat owners do not have a higher seroprevalence of T. gondii compared to non-owners when dietary and environmental factors are controlled [6]. Studies on veterinary medicine professionals and students show that occupational exposure to cats does not necessarily correlate with higher seroprevalence, provided hygiene protocols are followed [17]. The primary risk factors for human toxoplasmosis include consuming raw or undercooked meat, using untreated water, and gardening in contaminated soil without gloves [18, 19]. Public knowledge about these transmission routes is often poor, even among pregnant women, indicating the need for targeted education [18].

The stigma associated with the "cat lady" stereotype is also harmful to feline welfare. It can lead to abandonment or reluctance to adopt cats, yet the actual risk from a responsibly managed indoor cat is negligible [19]. Proper litter box hygiene, including daily removal of feces (before oocysts sporulate), cooking meat thoroughly, and wearing gloves when gardening, effectively minimizes zoonotic transmission [20]. A single-cell atlas of feline intestinal infection has shown that oocyst shedding patterns are tightly regulated and temporally limited, further underscoring that the risk window for zoonotic transmission is narrow [2].

Diagnostic Approaches

The diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and clinical assessments, as oocyst shedding is intermittent and frequently missed on routine fecal examination.

Serological Testing

Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most commonly employed diagnostic method. Commercial ELISA kits and indirect immunofluorescence assays can differentiate acute from chronic infection. In feline patients, a positive IgM titer suggests recent infection or reactivation, while a positive IgG titer indicates prior exposure. Seroprevalence studies in cats from Jordan and Hong Kong have relied on commercial ELISA platforms [4, 5]. Recent advances include the development of double-antigen sandwich colloidal gold immunochromatographic strips (ICS) for the detection of T. gondii antibodies across multiple host species, offering rapid point-of-care testing in veterinary settings [21, 22]. A SAG1-based colloidal gold ICS has been validated for serological detection in swine, and similar platforms are being adapted for feline use [22]. These tests use recombinant T. gondii antigens (e.g., SAG1, MIC17A) to capture specific antibodies, providing results in 10 to 15 minutes without specialized equipment [21, 23]. MIC17A has shown particular promise as an entero-epithelial and chronic stage marker for feline toxoplasmosis, making it a candidate antigen for differentiating infection stages [23].

Molecular Detection

PCR-based assays targeting multicopy genes such as the B1 gene or the 529 bp repeat element offer high sensitivity and specificity for direct detection of T. gondii DNA in blood, tissues, aqueous humor, and feces [3, 24]. Fecal PCR is particularly valuable for detecting oocyst shedding, even when numbers are low, and can distinguish T. gondii from other coccidian parasites based on amplicon size or sequence [3]. A novel antisense PCR assay has been developed and evaluated for T. gondii detection in domestic cats, leveraging strand-specific amplification to improve diagnostic accuracy in low-copy-number samples [24]. Molecular detection in reproductive tissues (e.g., ovary, uterus) has also been reported, aiding in the diagnosis of vertical transmission cases [9].

Histopathology and Immunohistochemistry

For postmortem diagnosis or tissue biopsy analysis, histopathological examination can identify tachyzoites and tissue cysts in sections stained with hematoxylin and eosin. Immunohistochemistry using anti-T. gondii antibodies or in situ hybridization provides definitive confirmation of T. gondii infection within tissues. A study of aborted goat fetuses in Algeria used both molecular and histopathological detection to confirm T. gondii in myocardial tissues, demonstrating its utility in diagnosing reproductive disease [13]. These techniques are considered the gold standard for diagnosing active tissue infection.

flowchart TD
    A[Cat with suspect toxoplasmosis clinical signs], > B{Serology: IgG/IgM ELISA or ICS}
    B, >|IgM positive, IgG negative| C[Suspect acute infection]
    B, >|IgG positive, IgM negative| D[Chronic/latent infection]
    B, >|Both negative| E[No infection]
    C, > F{Perform fecal PCR}
    F, >|Positive| G[Active oocyst shedding; treat]
    F, >|Negative| H[Clinical workup: ocular exam, neuro exam]
    D, > I{Clinical signs present?}
    I, >|Yes| J[Consider reactivation; PCR on blood/AH]
    I, >|No| K[No treatment needed]
    H, > L[PCR on blood, CSF, or aqueous humor]
    L, >|Positive| M[Active tissue infection; treat]
    L, >|Negative| N[Rule out other etiologies]

Treatment and Management

Treatment of clinical feline toxoplasmosis is indicated for cats with active ocular, neurological, or systemic disease. The standard therapy is a combination of clindamycin (10-12 mg/kg orally twice daily for 2-4 weeks) or a dihydrofolate reductase inhibitor such as trimethoprim-sulfonamide (15 mg/kg twice daily). Clindamycin is the first-line drug chosen for its efficacy against tachyzoites, although it does not eliminate tissue cysts. In cases of ocular toxoplasmosis, topical corticosteroids may be added cautiously to control inflammation, but only after instituting antiparasitic therapy.

Supportive care is essential in severe cases and includes fluid therapy, nutritional support, and management of secondary infections. For cats with neurological symptoms, antiseizure medications (e.g., phenobarbital) may be required in addition to antiparasitic therapy.

Prevention and Control

Preventive strategies focus on reducing environmental oocyst contamination and minimizing feline exposure. The most effective control measures are:

• Keeping cats indoors to prevent hunting of infected prey (rodents, birds) [4, 5].
• Feeding only cooked or commercially processed food (not raw meat) [5].
• Daily removal of cat feces from the litter box to prevent oocyst sporulation [20].
• Regular cleaning of litter boxes with hot water (over 70 degrees Celsius) to inactivate oocysts.
• Wearing gloves and washing hands after gardening or handling soil in areas that may be contaminated by stray cats.

Vaccination against T. gondii in cats remains an active area of research. Gene-edited live-attenuated vaccines have shown promise in experimental models, including strains deficient in key metabolic pathways or virulence factors [25]. Recent advances in mRNA vaccine platforms and One Health strategies are being explored for multi-species protection, though no licensed feline vaccine is currently available [26]. For seronegative pregnant women or immunocompromised individuals, adopting a barrier-free handling protocol for the litter box (e.g., delegating the task to another household member) is a practical recommendation [20].

Understanding the difference between toxoplasmosis and cat scratch fever is also critical, as these conditions are frequently confused but have entirely different etiologies and management protocols. Clinicians should perform a differential diagnosis to rule out other infectious and non-infectious causes of uveitis, fever, and neurological signs [10].

Management of Oocyst Shedding

It is critical to recognize that most cats that shed oocysts are asymptomatic. Therefore, serological screening to identify cats that have already been infected (and thus are likely immune and not shedding) is sometimes implemented in multi-cat households or shelters. However, routine fecal examination for oocysts is insensitive. Molecular testing (PCR) of pooled fecal samples from a colony can be used to monitor shedding events without individually testing every animal. Environmental decontamination is challenging; oocysts are resistant to many disinfectants and can survive for extended periods in soil. The only reliably effective method is exposure to temperatures above 55 degrees Celsius or desiccation under low humidity.

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026.

[2] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026.

[3] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026.

[4] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026.

[5] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026.

[6] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026.

[7] Andrade ACS, Vieira FPR, Dos Santos IC, et al. Nonhuman Primates and Wild Felines as Environmental Bioindicators of Toxoplasma gondii and Leishmania spp. from a Brazilian Zoo. Vector Borne Zoonotic Dis. 2026.

[8] Tsakmakidis I, Moustakidis K, Alvanou MV, et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026.

[9] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026.

[10] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults: Refresher course]. Ophthalmologie. 2026.

[11] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026.

[12] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026.

[13] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026.

[14] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026.

[15] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026.

[16] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026.

[17] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026.

[18] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026.

[19] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026.

[20] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026.

[21] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026.

[22] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026.

[23] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026.

[24] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026.

[25] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026.

[26] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026.

[27] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026.

[28] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026.

[29] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026.

[30] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026.

[31] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026.

[32] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026.

[33] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026.

[34] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026.

[35] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.